Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected?

Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180(10):948-55

Italo Sampablo Hospiten, Cancun, Riviera Maya, Avda Bonampak Lote 7 MZA.2 SM.10, 77500 Quintana Roo, Cancun, Mexico

, MD PhD,

Mauro Carone Division of Pulmonary Disease, Fondazione Salvatore Maugeri, IRCCS, 70020 CASSANO MURGE (BA), Italy

, MD &

Sabina Antonela Antoniu Division of Pulmonary Disease, Fondazione Salvatore Maugeri, IRCCS, 70020 CASSANO MURGE (BA), Italy; Pulmonary Disease University Hospital, University of Medicine and Pharmacy “Gr.T.Popa” Iasi, Department of Internal Medicine II-Pulmonary Disease, 30 Dr I Cihac Str, 700115 Iasi, Romania +40 232 239408; +40 232 270918; [email protected]

, MD PhD

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected?

Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180(10):948-55

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected?

Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180(10):948-55

Citations (2)

Articles from other publishers (2)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date